Hepion Pharmaceuticals (FRA:336) Tax Rate % : 50.98% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Hepion Pharmaceuticals Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Hepion Pharmaceuticals's Tax Expense for the three months ended in Mar. 2024 was €-2.73 Mil. Hepion Pharmaceuticals's Pre-Tax Income for the three months ended in Mar. 2024 was €-5.36 Mil. Therefore, Hepion Pharmaceuticals's Tax Rate % for the quarter that ended in Mar. 2024 was 50.98%.

Hepion Pharmaceuticals Tax Rate % Historical Data

The historical data trend for Hepion Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hepion Pharmaceuticals Tax Rate % Chart

Hepion Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

11.44

-0.15

6.40

0.83

Hepion Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Rate %	Get a 7-Day Free Trial															-	-	-	3.57	50.98

Hepion Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Hepion Pharmaceuticals's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	-0.375	/	-45.24
	=	0.83 %

Hepion Pharmaceuticals's Tax Rate % for the quarter that ended in Mar. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2024 )	/	Pre-Tax Income (Q: Mar. 2024 )
	=	-2.731	/	-5.357
	=	50.98 %

Hepion Pharmaceuticals Tax Rate % Related Terms

Thank you for viewing the detailed overview of Hepion Pharmaceuticals's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hepion Pharmaceuticals (FRA:336) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hepion Pharmaceuticals Inc (FRA:336) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

HEPA:USA

Address

399 Thornall Street, First Floor, Edison, NJ, USA, 08837

Website

https://www.hepionpharma.com

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Hepion Pharmaceuticals (FRA:336) Headlines

No Headlines